







































































@DVR 0 2 0
MVR 6 17 8
AVR 11 1 2
TVR 1 0 0
OMC 2 0 0
人工弁
@B－S 8 18 7
L－K 5 3 2









































































































































































































































































































































’three groups． e．　 ．　warfarin　alon6　（conttol），
warf rin　with　trapidil　（TP）・of　300mg／day
and　dipyridamole　（’DP）　6f　300　mg／day．　The
aggregation　of　platelet　of　the　eontrol　group
did　not　change　through　36　months．・
　　TP　group　showed　a　decrease　in　platelet
aggregation　at　24　and　30　months　from　the　pre－
treatment　value．　The　aggregation　of　24
month．in　TP　was　significantly　lower’than
that　of　control．　There　whs　no　difference
of　platelet　aggregation　between　TP　and
DP　g oup．
　The　 ncidence　ofthromboembolism　of　control，
TP　and　DP　group　were　9．5％，　4．3％　and
7．’V％，　respectively．
　　These　data　suggest　that　the　supression　of
platelet　aggregation　．by　TP　and　DP　is
not　adequate　to　continue　for　long　time　and
TP　has　sim lar　anti－thrombotic　effect　to
DP．
